A detailed history of Abn Amro Bank N.V. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abn Amro Bank N.V. holds 1,919,002 shares of MRK stock, worth $178 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
1,919,002
Previous 1,881,070 2.02%
Holding current value
$178 Million
Previous $150 Billion 7.19%
% of portfolio
1.58%
Previous 1.95%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

BUY
$77.6 - $87.37 $2.94 Million - $3.31 Million
37,932 Added 2.02%
1,919,002 $161 Billion
Q2 2025

Aug 12, 2025

SELL
$73.47 - $87.12 $15.1 Million - $17.9 Million
-204,903 Reduced 9.82%
1,881,070 $150 Billion
Q1 2025

Aug 28, 2025

SELL
$83.01 - $101.02 $75.9 Million - $92.3 Million
-913,772 Reduced 32.69%
1,881,428 $168 Billion
Q4 2024

Aug 28, 2025

BUY
$96.31 - $114.76 $1.98 Million - $2.36 Million
20,542 Added 0.74%
2,795,200 $275 Billion
Q3 2024

Aug 28, 2025

BUY
$111.15 - $128.97 $42.8 Million - $49.7 Million
385,225 Added 16.12%
2,774,658 $313 Billion
Q2 2024

Aug 28, 2025

BUY
$123.8 - $132.96 $30.2 Million - $32.4 Million
243,599 Added 11.35%
2,389,433 $299 Billion
Q1 2024

Aug 28, 2025

BUY
$113.24 - $131.95 $520,111 - $606,046
4,593 Added 0.21%
2,145,834 $283 Billion
Q4 2023

Aug 28, 2025

BUY
$100.18 - $109.02 $26.1 Million - $28.4 Million
260,171 Added 13.83%
2,141,241 $235 Billion
Q3 2023

Aug 28, 2025

SELL
$102.95 - $114.33 $2.64 Million - $2.93 Million
-25,669 Reduced 1.22%
2,085,973 $215 Billion
Q2 2023

Aug 28, 2025

SELL
$108.61 - $118.38 $2.84 Million - $3.1 Million
-26,146 Reduced 1.22%
2,111,642 $244 Billion
Q1 2023

Aug 28, 2025

BUY
$102.94 - $114.86 $220 Million - $246 Million
2,137,788 New
2,137,788 $228 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Abn Amro Bank N.V. Portfolio

Follow Abn Amro Bank N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abn Amro Bank N.V., based on Form 13F filings with the SEC.

News

Stay updated on Abn Amro Bank N.V. with notifications on news.